Table 3.
Gene | Models | Site applied | Food intake | Energy expenditure | Body weight | Neuropeptide mRNA | Ref | |
---|---|---|---|---|---|---|---|---|
Proinflammatory cytokines | Tumor necrosis factor-α (TNF-α) | KO | Whole body | ↓ | Anti-obesity | 156,157 | ||
icv injection (low-dose) | Brain | ↑ | ↓ | Pomc↓, TRH↓, CRH↓ | 82,155 | |||
icv injection (high-dose) | Brain | ↓ | ↑ | Pomc↑, Agrp↓ | 82,312 | |||
TNF-α receptor 1 (TNFR1) | KO | Whole body | ↑ | ↑ | Anti-obesity | Pomc↓, Agrp↑, TRH↑ | 155,158 | |
Interleukin-1 (IL-1) | KO | Whole body | Mature-onset obesity | 164 | ||||
icv injection (high-dose) | Brain | ↓ | ↑ | ↓ | 83,84,313,314 | |||
Interleukin-1 receptor I (IL-1RI) | KO | Whole body | ↑ | ↓ | Mature-onset obesity | 165 | ||
IL-1 receptor antagonist (IL-1Ra) | KO | Whole body | ↓ or no change | ↑ or no change | ↓ | No changes | 341,342 | |
Interleukin-6 (IL-6) | KO | Whole body | ↑ | Mature-onset obesity | 166 | |||
icv injection (high-dose) or overexpression | Brain | ↓ | ↑ | ↓ | Pomc↑, Npy↓, Agrp↓ | 85,166, 169 | ||
Interleukin-18 (IL-18) | KO | Whole body | ↑ | ↓ | Mature-onset obesity | No changes | 86,315 | |
icv injection (high-dose) | Brain | ↓ | ↓ | 86 | ||||
Leukemia inhibitory factor (LIF) | icv injection or overexpression | Brain | ↓ | No change | ↓ | 87,168 | ||
Brain-derived neurotrophic factor (BDNF) | KO (+/−) | Whole body | ↑ | ↑ | ↑ | No changes | 167 | |
icv injection (high-dose) | Brain | ↓ | ↑ | ↓ | Pomc↑, Agrp↑, TRH↑ | 88,316 | ||
Ciliary neurotrophic factor (CNTF) | icv injection (high-dose) | Brain | ↓ | ↓ | Npy↓ | 89,317 | ||
GM-CSF | KO | Whole body | ↓ | Mature-onset obesity | No changes | 90 | ||
icv injection (high-dose) | Brain | ↓ | ↓ | Npy↓, Agrp↓ | ||||
Resistin | KO (+/−) | Whole body | ↓ | ↑ | 363 | |||
icv injection (high-dose) | Brain | ↓ | ↓ | CART↑, Npy↓ or ↑, Agrp↓ | 163,318 | |||
Proinflammatory factors | X box binding protein 1 (XBP1) | KO | Brain | ↑ | ↓ | ↑ | Npy↑, Agrp↑ | 74 |
IKKβ | KO | Brain | ↓ | Anti-obesity | 66 | |||
c-Jun N-terminal kinase 1 (JNK1) | KO | Whole body | Anti-obesity | 181 | ||||
KO | Brain | ↓ | ↑ | Anti-obesity | Agrp↑ | 75,76,187 | ||
Toll-like receptor 2 (TLR2) | KO | Whole body | Anti-obesity | 153 | ||||
Toll-like receptor 4 (TLR4) | KO | Whole body | 149 | |||||
MyD88 | KO | Brain | ↓ | ↑ | Anti-obesity | 68 | ||
PTP1B | KO | Whole body | ↑ | Anti-obesity | 204,205 | |||
KO | Brain | ↑ | Anti-obesity | 207 | ||||
SOCS3 | KO (+/−) | Whole body | ↓ | Anti-obesity | Npy↓, Agrp↓ | 198 | ||
KO | Brain | ↓ | Anti-obesity | leptin-induced Pomc↑ | 199 | |||
KO | POMC neuron | ↓ | ↑ | Anti-obesity | Pomc↑, Npy↓ | 77 | ||
KO | SF1 neuron | ↓ | ↓ | No change | 79 | |||
α-lipoic acid | icv injection | Brain | ↓ | ↑ | Anti-obesity | 226 | ||
AMPK 2α | KO | AGRP neuron | ↓ | No change | ↓ | 225 | ||
POMC neuron | ↑ | ↓ | ↑ | |||||
TSC1 (mTOR inhibitor) | KO | POMC | ↑ | ↑ | Pomc↓, Npy↑ | 237 | ||
Sirtuin 1 (SIRT1) | Chemical inhibitor or siRHA | Brain or arcuate | ↓ | ↓ | Pomc↑, Agrp↓ | 251 | ||
KO | AGRP neuron | ↓ | No change | ↓ | 252 | |||
KO | POMC neuron | ↓ | ↑ | 249 | ||||
KO | SF1 neuron | ↓ | ↑ | 250 | ||||
Sirtuin 3 (SIRT3) | KO | Whole body | ↓ | ↑ | 256 | |||
Sirtuin 6 (SIRT6) | KO | Brain | ↑ | Pomc↓ | 255 | |||
Lipoprotein receptor LRP1 | KO | Brain | ↑ | ↓ | ↑ | Npy↑, Agrp↑ | 335 | |
Lipoprotein lipase (LPL) | KO | Brain | ↑ | ↓ | ↑ | Npy↑, Agrp↑ | 336 | |
Fatty acid synthase (FAS) | KO | via RIP Cre | ↓ | ↑ | ↓ | 334 | ||
Long-chain fatty acyl-CoA | icv injection | Brain | ↓ | ↓ | Npy↓, Agrp↓ | 333 |
“High-dose” reflects the injected doses in ng or μg, while “low-dose” reflects the injected doses in pg. Abbreviations: KO, knockout; icv, intracerebroventricular; ↓ decrease; ↑ increase.